163 related articles for article (PubMed ID: 36259508)
1. Effect of Nintedanib Nanothermoreversible Hydrogel on Neovascularization in an Ocular Alkali Burn Rat Model.
Liu X; Wu S; Gong Y; Yang L
Curr Eye Res; 2022 Dec; 47(12):1578-1589. PubMed ID: 36259508
[TBL] [Abstract][Full Text] [Related]
2. AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model.
Li Q; Hua X; Li L; Zhou X; Tian Y; Deng Y; Zhang M; Yuan X; Chi W
Cell Commun Signal; 2022 May; 20(1):59. PubMed ID: 35524333
[TBL] [Abstract][Full Text] [Related]
3. URP20 improves corneal injury caused by alkali burns combined with pathogenic bacterial infection in rats.
Gong Y; Gao J; Li M; Zhang XL; Liao YH; Bao YB
Exp Eye Res; 2024 Jan; 238():109739. PubMed ID: 38042515
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
Lan C; Liu G; Huang L; Wang X; Tan J; Wang Y; Fan N; Zhu Y; Yu M; Liu X
Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):14. PubMed ID: 35446346
[TBL] [Abstract][Full Text] [Related]
5. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone and MicroRNA-204 Inhibit Corneal Neovascularization.
Zhang X; Wang G; Wang Q; Jiang R
Mil Med; 2024 Jan; 189(1-2):374-378. PubMed ID: 36043264
[TBL] [Abstract][Full Text] [Related]
7. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
8. The role of pirfenidone in alkali burn rat cornea.
Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of corneal alkali burns with Gly-thymosin β
Zhang W; Nie L; Du L; Chen W; Wu Z; Jin Y
Burns; 2017 Dec; 43(8):1742-1747. PubMed ID: 28602595
[TBL] [Abstract][Full Text] [Related]
11. Triptolide Suppresses Alkali Burn-Induced Corneal Angiogenesis Along with a Downregulation of VEGFA and VEGFC Expression.
Wang G; Li N; Lv X; Ahmed N; Li X; Liu H; Ma J; Zhang Y
Anat Rec (Hoboken); 2017 Jul; 300(7):1348-1355. PubMed ID: 28233432
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Lee CM; Jung WK; Na G; Lee DS; Park SG; Seo SK; Yang JW; Yea SS; Lee YM; Park WS; Choi IW
Cutan Ocul Toxicol; 2015 Mar; 34(1):53-60. PubMed ID: 24754407
[TBL] [Abstract][Full Text] [Related]
13. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
[TBL] [Abstract][Full Text] [Related]
15. Effect of nintedanib thermo-sensitive hydrogel on neovascularization in alkali burn rat model.
Gong Y; Wu GH; Zhang LY; Zhang Z; Liao YH; Liu XT
Int J Ophthalmol; 2020; 13(6):879-885. PubMed ID: 32566497
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.
Arima T; Uchiyama M; Nakano Y; Nagasaka S; Kang D; Shimizu A; Takahashi H
Sci Rep; 2017 Dec; 7(1):17763. PubMed ID: 29259285
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularization.
Jia C; Zhu W; Ren S; Xi H; Li S; Wang Y
Mol Vis; 2011; 17():2386-99. PubMed ID: 21921991
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study.
Jin H; Yang B; Jiang D; Ding Z; Xiong Y; Zeng X
BMC Ophthalmol; 2022 Nov; 22(1):455. PubMed ID: 36443679
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NADPH oxidases in alkali burn-induced corneal injury.
Gu XJ; Liu X; Chen YY; Zhao Y; Xu M; Han XJ; Liu QP; Yi JL; Li JM
Int J Mol Med; 2016 Jul; 38(1):75-82. PubMed ID: 27221536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
